Virax Biolabs Group Limited · NASDAQ:VRAX
James Foster reported a 24.90% stake in Virax Biolabs Group Limited (Schedule 13G)
Event Dec 31, 2022 · Filed Oct 29, 2025
James Foster reported a 24.90% stake in Virax Biolabs Group Limited, 287,987 shares, as a passive investor on Dec 31, 2022. Filed Oct 29, 2025 (Schedule 13G).
- Stake
- 24.90%
- Shares
- 287,987
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| James Foster | 24.90% | 287,987 |
Source
Related
- Virax Biolabs Group Limited
- James Foster
- Virax Biolabs Group Limited shareholders
- Schedule 13G/A · James Foster · Oct 29, 2025
- Schedule 13G/A · James Foster · Oct 29, 2025
- Schedule 13G/A · James Foster · Oct 29, 2025
- Schedule 13G/A · Armistice Capital, LLC · May 15, 2026
- Schedule 13G · Armistice Capital, LLC · Feb 17, 2026